US 6,645,978 B1Granted

Lipoxin A4 and its analogs for the treatment of dry eye

AssigneeAlcon Inc.

InventorsDaniel A. Gamache, Gustav Graff, Mark R. Hellberg, Peter G. Klimko, John M. Yanni

Life of this patent

Estimating the term…

Abstract

Ophthalmic compositions containing Lipoxin A4 and its analogs and methods of their use for treating dry eve are disclosed.

Claims5

Dependent claims

A method for the treatment of dry eye, which comprises administering to a mammalian patient, a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a compound is selected from the group consisting of:

pharmaceutically acceptable salts and esters thereof.

Dependencies are inferred from the claim text.

Facts

Application: 09/787,789Filed 23 Mar 2001 · us provisional application
Priority: 9 Nov 1999
Granted: 11 Nov 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 31/557
Medicinal preparations containing organic active ingredients: eicosanoids, e.g. leukotrienes or prostaglandins
A61P 27/02
Drugs for disorders of the senses: ophthalmic agents

Family

Application60/164,406Us provisional application · filed 9 Nov 1999
US 6,645,978 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results